InMed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,111,707 | $1,264 | $1,283 | $1,172 |
Gross Profit | 460,894 | 493 | -6,988,733 | 139 |
EBITDA | -2,099,854 | -1,609 | -2,042 | -2,358 |
EBIT | -2,153,056 | -1,754 | -2,193 | -2,509 |
Net Income | -2,575,024 | -1,677,868 | -1,937 | -1,722 |
Net Change In Cash | 1,111,707 | 1,264 | 1,283 | 1,172 |
Free Cash Flow | 1,822,481 | -1,826,810 | -1,029 | -1,964 |
Cash | 3,419,422 | 5,583 | 6,571 | 7,600 |
Basic Shares | 7,621 | 620,127 | 7,621,075 | 9,612 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $4,597 | $4,135 | $1,089 | $0 |
Gross Profit | 1,100 | 1,403 | 543 | -197 |
EBITDA | -7,063 | -10,831 | -17,257 | -9,801 |
EBIT | -7,668 | -11,427 | -17,769 | -9,998 |
Net Income | -7,675 | -7,947 | -18,600 | -10,200 |
Net Change In Cash | 4,597 | 4,135 | 1,089 | 0 |
Free Cash Flow | -6,995 | -7,445 | -15,622 | -9,792 |
Cash | 6,571 | 8,912 | 6,176 | 7,363 |
Basic Shares | 7,585 | 2,448 | 560 | 270 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$3.64 |
2024-09-30 | -$0.21 |
2024-06-30 | -$0.21 |
2024-03-31 | -$0.17 |
